Opinion

Video

Overview of the Port Delivery System with Ranibizumab

Margaret Chang, MD, examines the difficulties of frequent anti-VEGF injections and outlines the key aspects of the port delivery system (PDS) for ranibizumab administration.

  1. Why is sustained delivery of anti-VEGF necessary, and what challenges arise from frequent anti-VEGF injections?
  2. Can you provide an overview of the port delivery system with ranibizumab?
    1. How does the device function?
    2. How is the device implanted?
    3. How is the device refilled?
  3. What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?
Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
© 2024 MJH Life Sciences

All rights reserved.